Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

NCT03150108 ·Status: COMPLETED ·Phase: PHASE1

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

NCT00790101 ·Status: TERMINATED ·Phase: PHASE4

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

NCT00293813 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

NCT00439244 ·Status: COMPLETED ·Phase: PHASE3

Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty

NCT01358669 ·Status: COMPLETED ·Phase: PHASE2

The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

NCT00674453 ·Status: COMPLETED ·Phase: PHASE2

Nasally and sc Administered Teriparatide in Healthy Volunteers

NCT01913834 ·Status: UNKNOWN ·Phase: PHASE1

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

NCT00386360 ·Status: COMPLETED ·Phase: PHASE3

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

NCT00489918 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

NCT00163137 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

NCT02478879 ·Status: COMPLETED ·Phase: PHASE1

Glucocorticoids and Bone in Graves' Ophthalmopathy

NCT03122847 ·Status: COMPLETED

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

NCT02274623 ·Status: COMPLETED ·Phase: PHASE1

Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism

NCT06859580 ·Status: RECRUITING ·Phase: PHASE4

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

NCT00148915 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

NCT00577850 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

NCT04366726 ·Status: COMPLETED ·Phase: PHASE1

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

NCT03435094 ·Status: UNKNOWN

Bone Effects of Teriparatide Following Alendronate

NCT00191893 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

NCT00619957 ·Status: COMPLETED ·Phase: PHASE3

Abaloparatide Before Total Knee Arthroplasty

NCT04167163 ·Status: COMPLETED ·Phase: PHASE4

Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

NCT00097812 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis

NCT00632216 ·Status: COMPLETED ·Phase: PHASE4

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

NCT00577837 ·Status: COMPLETED ·Phase: PHASE2

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

NCT00402441 ·Status: COMPLETED ·Phase: PHASE4